-
1
-
-
84896961871
-
The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries
-
Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M, The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014 63 1123 1133. doi: 10.1016/j.jacc.2013.11.053.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 1123-1133
-
-
Ambrosy, A.P.1
Fonarow, G.C.2
Butler, J.3
Chioncel, O.4
Greene, S.J.5
Vaduganathan, M.6
Nodari, S.7
Lam, C.S.8
Sato, N.9
Shah, A.N.10
Gheorghiade, M.11
-
2
-
-
84950104119
-
Heart disease and stroke statistics-2016 update: A report from the American Heart Association
-
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 2016 133 e38 360. doi: 10.1161/CIR.0000000000000350.
-
(2016)
Circulation
, vol.133
, pp. e38-360
-
-
Mozaffarian, D.1
Benjamin, E.J.2
Go, A.S.3
Arnett, D.K.4
Blaha, M.J.5
Cushman, M.6
Das, S.R.7
De Ferranti, S.8
Despres, J.P.9
Fullerton, H.J.10
Howard, V.J.11
Huffman, M.D.12
Isasi, C.R.13
Jimenez, M.C.14
Judd, S.E.15
Kissela, B.M.16
Lichtman, J.H.17
Lisabeth, L.D.18
Liu, S.19
Mackey, R.H.20
Magid, D.J.21
McGuire, D.K.22
Mohler, E.R.23
Moy, C.S.24
Muntner, P.25
Mussolino, M.E.26
Nasir, K.27
Neumar, R.W.28
Nichol, G.29
Palaniappan, L.30
Pandey, D.K.31
Reeves, M.J.32
Rodriguez, C.J.33
Rosamond, W.34
Sorlie, P.D.35
Stein, J.36
Towfighi, A.37
Turan, T.N.38
Virani, S.S.39
Woo, D.40
Yeh, R.W.41
Turner, M.B.42
more..
-
3
-
-
79952444246
-
Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association
-
American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research b013e31820a55f5
-
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 2011 123 933 944. doi: 10.1161/CIR.0b013e31820a55f5.
-
(2011)
Circulation
, vol.123
, pp. 933-944
-
-
Heidenreich, P.A.1
Trogdon, J.G.2
Khavjou, O.A.3
Butler, J.4
Dracup, K.5
Ezekowitz, M.D.6
Finkelstein, E.A.7
Hong, Y.8
Johnston, S.C.9
Khera, A.10
Lloyd-Jones, D.M.11
Nelson, S.A.12
Nichol, G.13
Orenstein, D.14
Wilson, P.W.15
Woo, Y.J.16
-
4
-
-
77957730950
-
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure
-
PROTECT Investigators and Committees
-
Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, PROTECT Investigators and Committees Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010 363 1419 1428. doi: 10.1056/NEJMoa0912613.
-
(2010)
N Engl J Med
, vol.363
, pp. 1419-1428
-
-
Massie, B.M.1
O'Connor, C.M.2
Metra, M.3
Ponikowski, P.4
Teerlink, J.R.5
Cotter, G.6
Weatherley, B.D.7
Cleland, J.G.8
Givertz, M.M.9
Voors, A.10
DeLucca, P.11
Mansoor, G.A.12
Salerno, C.M.13
Bloomfield, D.M.14
Dittrich, H.C.15
-
5
-
-
34247857479
-
Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial
-
SURVIVE Investigators
-
Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M, SURVIVE Investigators Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial. JAMA 2007 297 1883 1891. doi: 10.1001/jama.297.17.1883.
-
(2007)
JAMA
, vol.297
, pp. 1883-1891
-
-
Mebazaa, A.1
Nieminen, M.S.2
Packer, M.3
Cohen-Solal, A.4
Kleber, F.X.5
Pocock, S.J.6
Thakkar, R.7
Padley, R.J.8
Põder, P.9
Kivikko, M.10
-
6
-
-
84875176312
-
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial
-
ASTRONAUT Investigators and Coordinators
-
Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP, ASTRONAUT Investigators and Coordinators Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial. JAMA 2013 309 1125 1135. doi: 10.1001/jama.2013.1954.
-
(2013)
JAMA
, vol.309
, pp. 1125-1135
-
-
Gheorghiade, M.1
Böhm, M.2
Greene, S.J.3
Fonarow, G.C.4
Lewis, E.F.5
Zannad, F.6
Solomon, S.D.7
Baschiera, F.8
Botha, J.9
Hua, T.A.10
Gimpelewicz, C.R.11
Jaumont, X.12
Lesogor, A.13
Maggioni, A.P.14
-
7
-
-
33947713810
-
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
-
Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
-
Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA 2007 297 1319 1331. doi: 10.1001/jama.297.12.1319.
-
(2007)
JAMA
, vol.297
, pp. 1319-1331
-
-
Konstam, M.A.1
Gheorghiade, M.2
Burnett, J.C.3
Grinfeld, L.4
Maggioni, A.P.5
Swedberg, K.6
Udelson, J.E.7
Zannad, F.8
Cook, T.9
Ouyang, J.10
Zimmer, C.11
Orlandi, C.12
-
8
-
-
35848944656
-
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials
-
VERITAS Investigators
-
McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobrin I, VERITAS Investigators Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials. JAMA 2007 298 2009 2019. doi: 10.1001/jama.298.17.2009.
-
(2007)
JAMA
, vol.298
, pp. 2009-2019
-
-
McMurray, J.J.1
Teerlink, J.R.2
Cotter, G.3
Bourge, R.C.4
Cleland, J.G.5
Jondeau, G.6
Krum, H.7
Metra, M.8
O'Connor, C.M.9
Parker, J.D.10
Torre-Amione, G.11
Van Veldhuisen, D.J.12
Lewsey, J.13
Frey, A.14
Rainisio, M.15
Kobrin, I.16
-
9
-
-
84969166491
-
Developing new treatments for heart failure: Focus on the heart
-
Gheorghiade M, Larson CJ, Shah SJ, Greene SJ, Cleland JG, Colucci WS, Dunnmon P, Epstein SE, Kim RJ, Parsey RV, Stockbridge N, Carr J, Dinh W, Krahn T, Kramer F, Wahlander K, Deckelbaum LI, Crandall D, Okada S, Senni M, Sikora S, Sabbah HN, Butler J, Developing new treatments for heart failure: focus on the heart. Circ Heart Fail 2016 9 e002727. doi: 10.1161/CIRCHEARTFAILURE.115.002727.
-
(2016)
Circ Heart Fail
, vol.9
, pp. e002727
-
-
Gheorghiade, M.1
Larson, C.J.2
Shah, S.J.3
Greene, S.J.4
Cleland, J.G.5
Colucci, W.S.6
Dunnmon, P.7
Epstein, S.E.8
Kim, R.J.9
Parsey, R.V.10
Stockbridge, N.11
Carr, J.12
Dinh, W.13
Krahn, T.14
Kramer, F.15
Wahlander, K.16
Deckelbaum, L.I.17
Crandall, D.18
Okada, S.19
Senni, M.20
Sikora, S.21
Sabbah, H.N.22
Butler, J.23
more..
-
10
-
-
84873098252
-
The disconnect between phase II and phase III trials of drugs for heart failure
-
Vaduganathan M, Greene SJ, Ambrosy AP, Gheorghiade M, Butler J, The disconnect between phase II and phase III trials of drugs for heart failure. Nat Rev Cardiol 2013 10 85 97. doi: 10.1038/nrcardio.2012.181.
-
(2013)
Nat Rev Cardiol
, vol.10
, pp. 85-97
-
-
Vaduganathan, M.1
Greene, S.J.2
Ambrosy, A.P.3
Gheorghiade, M.4
Butler, J.5
-
11
-
-
84926175615
-
Improving cardiovascular clinical trials conduct in the United States: Recommendation from clinicians, researchers, sponsors, and regulators
-
Butler J, Fonarow GC, O'Connor C, Adams K, Bonow RO, Cody RJ, Collins SP, Dunnmon P, Dinh W, Fiuzat M, Georgiopoulou VV, Grant S, Kim SY, Kupfer S, Lefkowitz M, Mentz RJ, Misselwitz F, Pitt B, Roessig L, Schelbert E, Shah M, Solomon S, Stockbridge N, Yancy C, Gheorghiade M, Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators. Am Heart J 2015 169 305 314. doi: 10.1016/j.ahj.2014.12.001.
-
(2015)
Am Heart J
, vol.169
, pp. 305-314
-
-
Butler, J.1
Fonarow, G.C.2
O'Connor, C.3
Adams, K.4
Bonow, R.O.5
Cody, R.J.6
Collins, S.P.7
Dunnmon, P.8
Dinh, W.9
Fiuzat, M.10
Georgiopoulou, V.V.11
Grant, S.12
Kim, S.Y.13
Kupfer, S.14
Lefkowitz, M.15
Mentz, R.J.16
Misselwitz, F.17
Pitt, B.18
Roessig, L.19
Schelbert, E.20
Shah, M.21
Solomon, S.22
Stockbridge, N.23
Yancy, C.24
Gheorghiade, M.25
more..
-
12
-
-
84992061040
-
Transforming drug development in heart failure: Navigating the regulatory crossroads
-
Vaduganathan M, Butler J, Gheorghiade M, Transforming drug development in heart failure: navigating the regulatory crossroads. Circ Heart Fail 2016 9 e003192. doi: 10.1161/CIRCHEARTFAILURE.116.003192.
-
(2016)
Circ Heart Fail
, vol.9
, pp. e003192
-
-
Vaduganathan, M.1
Butler, J.2
Gheorghiade, M.3
-
13
-
-
84995784708
-
Exploring new endpoints for patients with heart failure with preserved ejection fraction
-
Butler J, Hamo CE, Udelson JE, Pitt B, Yancy C, Shah SJ, Desvigne-Nickens P, Bernstein HS, Clark RL, Depre C, Dinh W, Hamer A, Kay-Mugford P, Kramer F, Lefkowitz M, Lewis K, Maya J, Maybaum S, Patel MJ, Pollack PS, Roessig L, Rotman S, Salsali A, Sims JJ, Senni M, Rosano G, Dunnmon P, Stockbridge N, Anker SD, Zile MR, Gheorghiade M, Exploring new endpoints for patients with heart failure with preserved ejection fraction. Circ Heart Fail 2016 9 e003358. doi: 10.1161/CIRCHEARTFAILURE.116.003358.
-
(2016)
Circ Heart Fail
, vol.9
, pp. e003358
-
-
Butler, J.1
Hamo, C.E.2
Udelson, J.E.3
Pitt, B.4
Yancy, C.5
Shah, S.J.6
Desvigne-Nickens, P.7
Bernstein, H.S.8
Clark, R.L.9
Depre, C.10
Dinh, W.11
Hamer, A.12
Kay-Mugford, P.13
Kramer, F.14
Lefkowitz, M.15
Lewis, K.16
Maya, J.17
Maybaum, S.18
Patel, M.J.19
Pollack, P.S.20
Roessig, L.21
Rotman, S.22
Salsali, A.23
Sims, J.J.24
Senni, M.25
Rosano, G.26
Dunnmon, P.27
Stockbridge, N.28
Anker, S.D.29
Zile, M.R.30
Gheorghiade, M.31
more..
-
14
-
-
66949126764
-
Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality?
-
Gheorghiade M, Pang PS, Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol 2009 53 2349 2352. doi: 10.1016/j.jacc.2009.01.075.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 2349-2352
-
-
Gheorghiade, M.1
Pang, P.S.2
-
15
-
-
68849114272
-
Biomarker-guided therapy in chronic heart failure: A meta-Analysis of randomized controlled trials
-
Felker GM, Hasselblad V, Hernandez AF, O'Connor CM, Biomarker-guided therapy in chronic heart failure: A meta-Analysis of randomized controlled trials. Am Heart J 2009 158 422 430. doi: 10.1016/j.ahj.2009.06.018.
-
(2009)
Am Heart J
, vol.158
, pp. 422-430
-
-
Felker, G.M.1
Hasselblad, V.2
Hernandez, A.F.3
O'Connor, C.M.4
-
16
-
-
0037142946
-
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial
-
Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study
-
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002 360 196 202
-
(2002)
Lancet
, vol.360
, pp. 196-202
-
-
Follath, F.1
Cleland, J.G.2
Just, H.3
Papp, J.G.4
Scholz, H.5
Peuhkurinen, K.6
Harjola, V.P.7
Mitrovic, V.8
Abdalla, M.9
Sandell, E.P.10
Lehtonen, L.11
-
17
-
-
84941069645
-
Targeting the heart" in heart failure: Myocardial recovery in heart failure with reduced ejection fraction
-
Wilcox JE, Fonarow GC, Ardehali H, Bonow RO, Butler J, Sauer AJ, Epstein SE, Khan SS, Kim RJ, Sabbah HN, Díez J, Gheorghiade M, "Targeting the heart" in heart failure: myocardial recovery in heart failure with reduced ejection fraction. JACC Heart Fail 2015 3 661 669. doi: 10.1016/j.jchf.2015.04.011.
-
(2015)
JACC Heart Fail
, vol.3
, pp. 661-669
-
-
Wilcox, J.E.1
Fonarow, G.C.2
Ardehali, H.3
Bonow, R.O.4
Butler, J.5
Sauer, A.J.6
Epstein, S.E.7
Khan, S.S.8
Kim, R.J.9
Sabbah, H.N.10
Díez, J.11
Gheorghiade, M.12
-
18
-
-
77955293973
-
Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: A meta-Analytic approach
-
Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE, Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: A meta-Analytic approach. J Am Coll Cardiol 2010 56 392 406. doi: 10.1016/j.jacc.2010.05.011.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 392-406
-
-
Kramer, D.G.1
Trikalinos, T.A.2
Kent, D.M.3
Antonopoulos, G.V.4
Konstam, M.A.5
Udelson, J.E.6
-
19
-
-
0038690110
-
Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure
-
Khattar RS, Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure. Minerva Cardioangiol 2003 51 143 154
-
(2003)
Minerva Cardioangiol
, vol.51
, pp. 143-154
-
-
Khattar, R.S.1
-
20
-
-
77954739690
-
Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-To-moderate heart failure and left ventricular systolic dysfunction
-
Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA, Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-To-moderate heart failure and left ventricular systolic dysfunction. Circ Heart Fail 2010 3 347 353. doi: 10.1161/CIRCHEARTFAILURE.109.906909.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 347-353
-
-
Udelson, J.E.1
Feldman, A.M.2
Greenberg, B.3
Pitt, B.4
Mukherjee, R.5
Solomon, H.A.6
Konstam, M.A.7
-
21
-
-
84898713808
-
Spironolactone for heart failure with preserved ejection fraction
-
TOPCAT Investigators
-
Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014 370 1383 1392. doi: 10.1056/NEJMoa1313731.
-
(2014)
N Engl J Med
, vol.370
, pp. 1383-1392
-
-
Pitt, B.1
Pfeffer, M.A.2
Assmann, S.F.3
Boineau, R.4
Anand, I.S.5
Claggett, B.6
Clausell, N.7
Desai, A.S.8
Diaz, R.9
Fleg, J.L.10
Gordeev, I.11
Harty, B.12
Heitner, J.F.13
Kenwood, C.T.14
Lewis, E.F.15
O'Meara, E.16
Probstfield, J.L.17
Shaburishvili, T.18
Shah, S.J.19
Solomon, S.D.20
Sweitzer, N.K.21
Yang, S.22
McKinlay, S.M.23
more..
-
22
-
-
84925744564
-
Left atrium in heart failure with preserved ejection fraction: Structure, function, and significance
-
Rossi A, Gheorghiade M, Triposkiadis F, Solomon SD, Pieske B, Butler J, Left atrium in heart failure with preserved ejection fraction: structure, function, and significance. Circ Heart Fail 2014 7 1042 1049. doi: 10.1161/CIRCHEARTFAILURE.114.001276.
-
(2014)
Circ Heart Fail
, vol.7
, pp. 1042-1049
-
-
Rossi, A.1
Gheorghiade, M.2
Triposkiadis, F.3
Solomon, S.D.4
Pieske, B.5
Butler, J.6
-
23
-
-
84867745957
-
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial
-
for the Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators
-
Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ, for the Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial. Lancet 2012 380 1387 1395. doi: 10.1016/S0140-6736(12)61227-6.
-
(2012)
Lancet
, vol.380
, pp. 1387-1395
-
-
Solomon, S.D.1
Zile, M.2
Pieske, B.3
Voors, A.4
Shah, A.5
Kraigher-Krainer, E.6
Shi, V.7
Bransford, T.8
Takeuchi, M.9
Gong, J.10
Lefkowitz, M.11
Packer, M.12
McMurray, J.J.13
-
24
-
-
84947757783
-
Prognostic importance of changes in cardiac structure and function in heart failure with preserved ejection fraction and the impact of spironolactone
-
Shah AM, Claggett B, Sweitzer NK, Shah SJ, Deswal A, Anand IS, Fleg JL, Pitt B, Pfeffer MA, Solomon SD, Prognostic importance of changes in cardiac structure and function in heart failure with preserved ejection fraction and the impact of spironolactone. Circ Heart Fail 2015 8 1052 1058. doi: 10.1161/CIRCHEARTFAILURE.115.002249.
-
(2015)
Circ Heart Fail
, vol.8
, pp. 1052-1058
-
-
Shah, A.M.1
Claggett, B.2
Sweitzer, N.K.3
Shah, S.J.4
Deswal, A.5
Anand, I.S.6
Fleg, J.L.7
Pitt, B.8
Pfeffer, M.A.9
Solomon, S.D.10
-
25
-
-
57349142933
-
Irbesartan in patients with heart failure and preserved ejection fraction
-
I-PRESERVE Investigators
-
Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008 359 2456 2467. doi: 10.1056/NEJMoa0805450.
-
(2008)
N Engl J Med
, vol.359
, pp. 2456-2467
-
-
Massie, B.M.1
Carson, P.E.2
McMurray, J.J.3
Komajda, M.4
McKelvie, R.5
Zile, M.R.6
Anderson, S.7
Donovan, M.8
Iverson, E.9
Staiger, C.10
Ptaszynska, A.11
-
26
-
-
84877973822
-
Evaluative framework for phase II studies in patients with heart failure and preserved ejection fraction
-
Gheorghiade M, Vaduganathan M, Shah SJ, Evaluative framework for phase II studies in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2013 1 123 126. doi: 10.1016/j.jchf.2013.01.001.
-
(2013)
JACC Heart Fail
, vol.1
, pp. 123-126
-
-
Gheorghiade, M.1
Vaduganathan, M.2
Shah, S.J.3
-
27
-
-
77951891036
-
Clinical trials of pharmacological therapies in acute heart failure syndromes: Lessons learned and directions forward
-
International AHFS Working Group
-
Felker GM, Pang PS, Adams KF, Cleland JG, Cotter G, Dickstein K, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pina IL, Ponikowski P, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Gheorghiade M, International AHFS Working Group Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail 2010 3 314 325. doi: 10.1161/CIRCHEARTFAILURE.109.893222.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 314-325
-
-
Felker, G.M.1
Pang, P.S.2
Adams, K.F.3
Cleland, J.G.4
Cotter, G.5
Dickstein, K.6
Filippatos, G.S.7
Fonarow, G.C.8
Greenberg, B.H.9
Hernandez, A.F.10
Khan, S.11
Komajda, M.12
Konstam, M.A.13
Liu, P.P.14
Maggioni, A.P.15
Massie, B.M.16
McMurray, J.J.17
Mehra, M.18
Metra, M.19
O'Connell, J.20
O'Connor, C.M.21
Pina, I.L.22
Ponikowski, P.23
Sabbah, H.N.24
Teerlink, J.R.25
Udelson, J.E.26
Yancy, C.W.27
Zannad, F.28
Gheorghiade, M.29
more..
-
28
-
-
79960090547
-
Effect of nesiritide in patients with acute decompensated heart failure
-
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Wilson WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM, Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011 365 32 43. doi: 10.1056/NEJMoa1100171.
-
(2011)
N Engl J Med
, vol.365
, pp. 32-43
-
-
O'Connor, C.M.1
Starling, R.C.2
Hernandez, A.F.3
Armstrong, P.W.4
Dickstein, K.5
Hasselblad, V.6
Heizer, G.M.7
Komajda, M.8
Massie, B.M.9
McMurray, J.J.10
Nieminen, M.S.11
Reist, C.J.12
Rouleau, J.L.13
Swedberg, K.14
Adams, K.F.15
Anker, S.D.16
Atar, D.17
Battler, A.18
Botero, R.19
Bohidar, N.R.20
Butler, J.21
Clausell, N.22
Corbalán, R.23
Costanzo, M.R.24
Dahlstrom, U.25
Deckelbaum, L.I.26
Diaz, R.27
Dunlap, M.E.28
Ezekowitz, J.A.29
Feldman, D.30
Felker, G.M.31
Fonarow, G.C.32
Gennevois, D.33
Gottlieb, S.S.34
Hill, J.A.35
Hollander, J.E.36
Howlett, J.G.37
Hudson, M.P.38
Kociol, R.D.39
Krum, H.40
Laucevicius, A.41
Levy, W.C.42
Méndez, G.F.43
Metra, M.44
Mittal, S.45
Oh, B.H.46
Pereira, N.L.47
Ponikowski, P.48
Tang, W.H.49
Wilson, W.H.50
Tanomsup, S.51
Teerlink, J.R.52
Triposkiadis, F.53
Troughton, R.W.54
Voors, A.A.55
Whellan, D.J.56
Zannad, F.57
Califf, R.M.58
more..
-
29
-
-
52949105070
-
The PROTECT pilot study: A randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment
-
Protect Steering Committee, Investigators, and Coordinators
-
Cotter G, Dittrich HC, Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM, Protect Steering Committee, Investigators, and Coordinators The PROTECT pilot study: A randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 2008 14 631 640. doi: 10.1016/j.cardfail.2008.08.010.
-
(2008)
J Card Fail
, vol.14
, pp. 631-640
-
-
Cotter, G.1
Dittrich, H.C.2
Weatherley, B.D.3
Bloomfield, D.M.4
O'Connor, C.M.5
Metra, M.6
Massie, B.M.7
-
30
-
-
80054753558
-
Worsening kidney function in decompensated heart failure: Treat the heart, don't mind the kidney
-
Ruggenenti P, Remuzzi G, Worsening kidney function in decompensated heart failure: Treat the heart, don't mind the kidney. Eur Heart J 2011 32 2476 2478. doi: 10.1093/eurheartj/ehr242.
-
(2011)
Eur Heart J
, vol.32
, pp. 2476-2478
-
-
Ruggenenti, P.1
Remuzzi, G.2
-
31
-
-
84859634464
-
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? the role of congestion and its interaction with renal function
-
Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L, Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 2012 5 54 62. doi: 10.1161/CIRCHEARTFAILURE.111.963413.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 54-62
-
-
Metra, M.1
Davison, B.2
Bettari, L.3
Sun, H.4
Edwards, C.5
Lazzarini, V.6
Piovanelli, B.7
Carubelli, V.8
Bugatti, S.9
Lombardi, C.10
Cotter, G.11
Dei Cas, L.12
-
32
-
-
84964394028
-
Trends in utilization of surrogate endpoints in contemporary cardiovascular clinical trials
-
Patel RB, Vaduganathan M, Samman-Tahhan A, Kalogeropoulos AP, Georgiopoulou VV, Fonarow GC, Gheorghiade M, Butler J, Trends in utilization of surrogate endpoints in contemporary cardiovascular clinical trials. Am J Cardiol 2016 117 1845 1850. doi: 10.1016/j.amjcard.2016.03.021.
-
(2016)
Am J Cardiol
, vol.117
, pp. 1845-1850
-
-
Patel, R.B.1
Vaduganathan, M.2
Samman-Tahhan, A.3
Kalogeropoulos, A.P.4
Georgiopoulou, V.V.5
Fonarow, G.C.6
Gheorghiade, M.7
Butler, J.8
-
33
-
-
0021666221
-
Procedures for comparing samples with multiple endpoints
-
O'Brien PC, Procedures for comparing samples with multiple endpoints. Biometrics 1984 40 1079 1087
-
(1984)
Biometrics
, vol.40
, pp. 1079-1087
-
-
O'Brien, P.C.1
-
34
-
-
84873666783
-
Evaluating treatment efficacy by multiple end points in phase II acute heart failure clinical trials: Analyzing data using a global method
-
Sun H, Davison BA, Cotter G, Pencina MJ, Koch GG, Evaluating treatment efficacy by multiple end points in phase II acute heart failure clinical trials: Analyzing data using a global method. Circ Heart Fail 2012 5 742 749. doi: 10.1161/CIRCHEARTFAILURE.112.969154.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 742-749
-
-
Sun, H.1
Davison, B.A.2
Cotter, G.3
Pencina, M.J.4
Koch, G.G.5
-
35
-
-
80054771951
-
Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: Lessons from Pre-RELAX-AHF
-
Davison BA, Cotter G, Sun H, Chen L, Teerlink JR, Metra M, Felker GM, Voors AA, Ponikowski P, Filippatos G, Greenberg B, Teichman SL, Unemori E, Koch GG, Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF. Clin Res Cardiol 2011 100 745 753. doi: 10.1007/s00392-011-0304-5.
-
(2011)
Clin Res Cardiol
, vol.100
, pp. 745-753
-
-
Davison, B.A.1
Cotter, G.2
Sun, H.3
Chen, L.4
Teerlink, J.R.5
Metra, M.6
Felker, G.M.7
Voors, A.A.8
Ponikowski, P.9
Filippatos, G.10
Greenberg, B.11
Teichman, S.L.12
Unemori, E.13
Koch, G.G.14
-
36
-
-
1042278919
-
Selection of endpoints for heart failure clinical trials
-
Zanolla L, Zardini P, Selection of endpoints for heart failure clinical trials. Eur J Heart Fail 2003 5 717 723
-
(2003)
Eur J Heart Fail
, vol.5
, pp. 717-723
-
-
Zanolla, L.1
Zardini, P.2
-
37
-
-
0033564460
-
Combining mortality and longitudinal measures in clinical trials
-
Finkelstein DM, Schoenfeld DA, Combining mortality and longitudinal measures in clinical trials. Stat Med 1999 18 1341 1354
-
(1999)
Stat Med
, vol.18
, pp. 1341-1354
-
-
Finkelstein, D.M.1
Schoenfeld, D.A.2
-
38
-
-
84994184221
-
Composite end points in acute heart failure research: Data simulations illustrate the limitations
-
Brown PM, Anstrom KJ, Felker GM, Ezekowitz JA, Composite end points in acute heart failure research: data simulations illustrate the limitations. Can J Cardiol 2016 32 1356.e21 1356.e28. doi: 10.1016/j.cjca.2016.02.067.
-
(2016)
Can J Cardiol
, vol.32
, pp. 1356e21-1356e28
-
-
Brown, P.M.1
Anstrom, K.J.2
Felker, G.M.3
Ezekowitz, J.A.4
-
39
-
-
84993881912
-
Evaluation of novel metrics of symptom relief in acute heart failure: The Worst Symptom Score
-
NHLBI Heart Failure Clinical Research Network
-
AbouEzzeddine OF, Wong YW, Mentz RJ, Raza SS, Nativi-Nicolau J, Kociol RD, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM, NHLBI Heart Failure Clinical Research Network Evaluation of novel metrics of symptom relief in acute heart failure: The Worst Symptom Score. J Card Fail 2016 22 853 858. doi: 10.1016/j.cardfail.2015.12.015.
-
(2016)
J Card Fail
, vol.22
, pp. 853-858
-
-
AbouEzzeddine, O.F.1
Wong, Y.W.2
Mentz, R.J.3
Raza, S.S.4
Nativi-Nicolau, J.5
Kociol, R.D.6
McNulty, S.E.7
Anstrom, K.J.8
Hernandez, A.F.9
Redfield, M.M.10
|